Latest Wegener's Granulomatosis Stories
In patients with a devastating form of vasculitis who are in remission, stress can be associated with a greater likelihood of the disease flaring.
In some kidney diseases, patients have high blood levels of a protein that blocks blood vessel repair.
SILVER SPRING, Md., April 19, 2011 /PRNewswire-USNewswire/ -- The U.S.
In a comparison of treatments for maintaining remission of a certain type of vasculitis (inflammation of blood vessels), the immunosuppressant mycophenolate mofetil, regarded as an alternative to the drug often used to prevent relapse, azathioprine, was less effective.
Investigators have made a major advance in treating people with a severe form of vasculitis, anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis, a rare but devastating disease of blood vessels.
Researchers have reported that Rituximab, a drug that is FDA approved to treat B cell lymphoma and rheumatoid arthritis, can also treat severe vasculitis as well as the current standard therapy.
Two UNC School of Medicine faculty authored an editorial in the July 15, 2010 New England Journal of Medicine commenting on results from two clinical trials using the drug Rituximab to treat small-vessel vasculitis, a rare autoimmune disease.
JOHNS CREEK, Ga., June 15 /PRNewswire-FirstCall/ -- Wegener Corporation (Other OTC: WGNR), a leading provider of products for television, audio and data distribution networks worldwide, today announced preliminary operating results for the third quarter ended May 28, 2010.
DULUTH, Ga., March 9 /PRNewswire-FirstCall/ -- Wegener Corporation, (Nasdaq: WGNR) a leading provider of products for television, audio and data distribution networks worldwide, today announced preliminary operating results for the second quarter ended February 26, 2010.
- a meat pie that is usually eaten at Christmas in Quebec